Invention Grant
- Patent Title: Hydroxy-substituted orexin receptor antagonists
-
Application No.: US14786031Application Date: 2014-04-21
-
Publication No.: US09725434B2Publication Date: 2017-08-08
- Inventor: Scott D. Kuduk , Nigel L. Liverton , Jason W. Skudlarek
- Applicant: MERCK SHARP & DOHME CORP.
- Applicant Address: US NJ Rahway
- Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee: MERCK SHARP & DOHME CORP.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; John C. Todaro
- International Application: PCT/US2014/034745 WO 20140421
- International Announcement: WO2014/176142 WO 20141030
- Main IPC: C07D401/10
- IPC: C07D401/10 ; C07D409/14 ; C07D401/14 ; C07D401/12
Abstract:
The present invention is directed to hydroxy compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Public/Granted literature
- US20160068510A1 HYDROXY-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS Public/Granted day:2016-03-10
Information query
